{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:25:43Z","timestamp":1780050343798,"version":"3.53.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease. Myasthenia gravis (MG) is a rare autoimmune disease caused by antibodies against the neuromuscular junction. PD and comorbid MG are rarely seen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>Here we report on a patient who was diagnosed with PD and MG. A 74-year-old man had a 4-year history of bradykinesia and was diagnosed with PD. He subsequently developed incomplete palpebral ptosis, apparent dropped head, and shuffling of gait. The results of neostigmine tests were positive. Repetitive nerve stimulation (RNS) showed significant decremental responses at 3 and 5 Hz in the orbicularis oculi. The patient's anti-acetylcholine receptor (anti-AchR) antibody serum level was also elevated. Meanwhile, 9-[<jats:sup>18<\/jats:sup>F]fluoropropyl-(+)-dihydrotetrabenazine positron emission tomography\u2013computed tomography (<jats:sup>18<\/jats:sup>F-AV133 PET-CT) scan revealed a significant decrease in uptake in the bilateral putamen. After addition of cholinesterase inhibitors, his symptoms of palpebral ptosis and head drop improved greatly and he showed a good response to levodopa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although PD with MG is rare, we still need to notice the possibility that a PD patient may have comorbid MG. The underlying mechanism of PD and comorbid MG remains unknown, but an imbalance between the neurotransmitters dopamine and acetylcholine and the immune system are likely to play significant roles in the pathogenesis. In this article, we present our case and a literature review on the co-occurrence of PD and MG, reviewing their clinical features, and discuss the underlying pathogenic mechanism of this comorbidity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1303434","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T04:25:05Z","timestamp":1704687905000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Parkinson's disease and comorbid myasthenia gravis: a case report and literature review"],"prefix":"10.3389","volume":"14","author":[{"given":"Qihao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","article-title":"The incidence of Parkinson's disease: a systematic review and meta-analysis","volume":"46","author":"Hirsch","year":"2016","journal-title":"Neuroepidemiology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0303-8467(93)90008-5","article-title":"Coexistence of Parkinson's disease and myasthenia gravis: a case report","volume":"95","author":"Kao","year":"1993","journal-title":"Clin Neurol Neurosurg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clineuro.2019.02.009","article-title":"rare cause of axial worsening in Parkinson's disease: a case of myasthenic pseudo-parkinsonism","volume":"179","author":"Marano","year":"2019","journal-title":"Clin Neurol Neurosurg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"931015","DOI":"10.3389\/fnagi.2022.931015","article-title":"Diagnostic value of striatal 18F-FP-DTBZ PET in Parkinson's disease","volume":"14","author":"Liu","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00207454.2022.2107517","article-title":"Myasthenia gravis crossing Parkinson's disease: a 20 year study from single Italian center","volume":"21","author":"Iori","year":"2022","journal-title":"Int J Neurosci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"VII21","DOI":"10.1007\/s00415-006-7006-3","article-title":"Dropped head in Parkinson's disease","volume":"253","author":"Fujimoto","year":"2006","journal-title":"J Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.nmd.2004.01.009","article-title":"The dropped head sign: an unusual presenting feature of myasthenia gravis","volume":"14","author":"Puruckherr","year":"2004","journal-title":"Neuromuscul Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/mus.25526","article-title":"Head-drop: a frequent feature of late-onset myasthenia gravis","volume":"56","author":"Sih","year":"2017","journal-title":"Muscle Nerve."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/mds.21634","article-title":"The phenomenon of disproportionate antecollis in Parkinson's disease and multiple system atrophy","volume":"22","author":"van de Warrenburg","year":"2007","journal-title":"Mov Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/NRL.0b013e3182173356","article-title":"Myasthenia gravis as a cause of head drop in Parkinson disease","volume":"17","author":"Uludag","year":"2011","journal-title":"Neurologist."},{"key":"B12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jns.2017.03.026","article-title":"Head drop in Parkinson's disease complicated by myasthenia gravis and myopathy","volume":"376","author":"Hogg","year":"2017","journal-title":"J Neurol Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/medicina56010005","article-title":"Patients with Parkinson's disease and myasthenia gravis-a report of three new cases and review of the literature","volume":"56","author":"Odajiu","year":"2019","journal-title":"Medicina."},{"key":"B14","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1212\/WNL.37.5.832","article-title":"Parkinson's disease and myasthenia gravis: adverse effect of trihexyphenidyl on neuromuscular transmission","volume":"37","author":"Ueno","year":"1987","journal-title":"Neurology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1600-0404.1988.tb03653.x","article-title":"Parkinsonism induced by pyridostigmine","volume":"78","author":"Iwasaki","year":"1988","journal-title":"Acta Neurol Scand."},{"key":"B16","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1111\/j.1447-0594.2010.00588.x","article-title":"Acetylcholine-dopamine balance hypothesis in the striatum: an update","volume":"10","author":"Aosaki","year":"2010","journal-title":"Geriatr Gerontol Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00415-003-1088-y","article-title":"Parkinson's disease associated with myasthenia gravis. A Report of 4 Cases","volume":"250","author":"Levin","year":"2003","journal-title":"J Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10072-014-1660-5","article-title":"Parkinson's disease associated with myasthenia gravis and rheumatoid arthritis","volume":"35","author":"Zis","year":"2014","journal-title":"Neurol Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat Rev Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000333222","article-title":"Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden","volume":"10","author":"Li","year":"2012","journal-title":"Neurodegener Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00702-012-0842-7","article-title":"Autoimmunity, dendritic cells and relevance for Parkinson's disease","volume":"120","author":"Koutsilieri","year":"2013","journal-title":"J Neural Transm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3389\/fimmu.2018.02047","article-title":"The challenge of the pathogenesis of Parkinson's disease: is autoimmunity the culprit?","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JPD-130250","article-title":"The role of innate and adaptive immunity in Parkinson's disease","volume":"3","author":"Kannarkat","year":"2013","journal-title":"J Parkinsons Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-140491","article-title":"Role of alpha-synuclein in inducing innate and adaptive immunity in Parkinson disease","volume":"5","author":"Allen Reish","year":"2015","journal-title":"J Parkinsons Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson's disease: autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/archneur.55.8.1075","article-title":"Experimental destruction of substantia nigra initiated by parkinson disease immunoglobulins","volume":"55","author":"Chen","year":"1998","journal-title":"Arch Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature."},{"key":"B28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-022-00282-2","article-title":"Transcriptional analysis of peripheral memory T cells reveals Parkinson's disease-specific gene signatures","volume":"8","author":"Dhanwani","year":"2022","journal-title":"NPJ Parkinsons Dis."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1303434\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T04:25:07Z","timestamp":1704687907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1303434\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":28,"alternative-id":["10.3389\/fneur.2023.1303434"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1303434","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"article-number":"1303434"}}